Dermapharm Holding SE (0A5J) Announces H1 2026 Revenue of EUR 591 Million with 10.3% Increase in Adjusted EBITDA

Dermapharm Holding SE (0A5J) Announces H1 2026 Revenue of EUR 591 Million with 10.3% Increase in Adjusted EBITDA →

Dermapharm Holding SE (0A5J), the Grfcnwald-based producer of branded pharmaceuticals and healthcare products, has reported consolidated revenue of EUR 591.0 million for the first half of 2026, marking a 2.9% increase year-over-year. Adjust…